Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association
10. Juni 2024 09:10 ET
|
Trinity Biotech plc
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics,...
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology
03. Juni 2024 04:00 ET
|
Trinity Biotech plc
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
23. Mai 2024 08:00 ET
|
Trinity Biotech plc
-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million by Q2 2025- -Strong sequential 39% Q/Q growth...
Trinity Biotech plc to Announce Q1 2024 Financial Results
21. Mai 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human...
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
16. Mai 2024 09:18 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
13. Mai 2024 11:42 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
08. Mai 2024 10:36 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
04. April 2024 07:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics,...
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
28. März 2024 18:39 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and...
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
08. März 2024 10:03 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC...